Ultrasound Elastography for Liver Fibrosis Staging

超声弹性成像用于肝纤维化分期

• 批准号: 9288188
• 负责人: Shigao Chen
• 金额: $ 42.45万
• 依托单位: MAYO CLINIC ROCHESTER
• 依托单位国家: 美国
• 财政年份: 2015
• 资助国家: 美国
• 起止时间: 2015-07-01 至 2019-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9288188
• 关键词: Adult; Agreement; Algorithms; American; Benchmarking; Biopsy; Body mass index; Clinic; Clinical; Code; Complex; Confidence Intervals; Data; Data Analyses; Detection; Elasticity; Evaluation; Failure; Fatty acid glycerol esters; Fibrosis; General Population; Generations; Human; Image; Imaging technology; Linear Regressions; Liver; Liver Fibrosis; Liver diseases; Magnetic Resonance Elastography; Maps; Measurement; Mechanics; Medical center; Meta-Analysis; Methods; Modeling; Noise; Obesity; Patients; Penetration; Performance; Prevalence; Radiation; Receiver Operating Characteristics; Recruitment Activity; Reference Standards; Reproducibility; Research; Sampling; Scanning; Signal Transduction; Source; Staging; Technology; Testing; Three-Dimensional Imaging; Time; Travel; Ultrasonography; Variant; attenuation; base; cost; elastography; healthy volunteer; in vivo; liver biopsy; nonalcoholic steatohepatitis; novel; portability; prototype; public health relevance; reconstruction; success; technology validation; validation studies; vibration

 DESCRIPTION (provided by applicant): Due to limitations of liver biopsy, there is a great need for noninvasive liver fibrosis staging. Ultrasound elastography has shown great promise for noninvasive liver fibrosis staging and may have higher clinical impact than Magnetic Resonance Elastography (MRE) due to its high accessibility and low cost. However, commercial elastography methods based on ultrasound radiation force have high failure rate in obese patients. This is a serious limitation considering the obesity prevalence in the U.S. general population (35.7%) and the increasing number of nonalcoholic steatohepatitis patients who are in need of liver fibrosis staging and are commonly obese. In this project, we will develop and validate a novel ultrasound imaging technology called Random External Vibration Ultrasound Elastography (REVUE) with superior penetration for liver fibrosis staging. REVUE uses external mechanical vibration to produce shear waves that penetrate throughout the liver. Advanced processing algorithms are employed to decompose the complex wave field into simpler unidirectional wave fields for reconstruction of large field-of-view quantitative elastography. The study has 3 aims. Aim 1: Implement and Advance REVUE on a traditional ultrasound scanner. We will implement REVUE on a traditional clinical scanner and investigate advanced shear wave generation, detection (by harmonic imaging and coded excitation), and processing methods to facilitate convenient clinical usage and reliable performance in obese patients. We will extend REVUE to 3D imaging for more accurate and comprehensive evaluation of the liver. Aim 1 includes phantom and preliminary human studies to validate the technologies developed. Aim 2: Repeatability and reproducibility study. We will use REVUE prototyped in Aim 1 to study 45 MRE patients. Each patient will have 3 REVUE imaging sessions: each session has 3 independent scans performed by 3 sonographers (a total of 9 scans). The first two sessions will be separated by a 10-minute break and the third performed on a different day. Intraclass correlation coefficients (ICC) will used to evaluate the test-retest repeatability and inter-rater agreement. The overall measurement variance will also be estimated for REVUE. Aim 3: In Vivo comparison with MRE. We will use REVUE to study 220 patients and compare results with those of MRE and a state-of-art ultrasound elastography machine (Aixplorer(r)). Data analysis includes measurement success rate, correlation with MRE results, and ROC (receiver operating characteristic) evaluation of performance for separating patients with minimum fibrosis (MRE = 2.9kPa) and patients with advanced fibrosis (MRE = 5.0kPa). Successful completion of this project will lead to a fast and low-cost ultrasound elastography method with deep penetration that meets the vital need for liver fibrosis staging in obese patients. The use of a traditional clinical ultrasound scanner in this proposal provides a clear path to clinical implementation of this technology.

 描述(申请人提供)：由于肝活检的局限性，非常需要无创肝纤维化分期。超声弹性成像在无创肝纤维化分期中显示出巨大的应用前景，由于其高可及性和低成本，可能比磁共振弹性成像(MRE)具有更高的临床影响。然而，基于超声辐射力的商业弹性成像方法在肥胖患者中失败率较高。考虑到美国普通人群中的肥胖率(35.7%)以及需要肝纤维化分期并普遍肥胖的非酒精性脂肪性肝炎患者的数量不断增加，这是一个严重的限制。在这个项目中，我们将开发和验证一种新的超声成像技术，称为随机外部振动超声弹性成像(REVUE)，具有优越的穿透性，用于肝纤维化分期。Revue使用外部机械振动产生横波，横波穿透整个肝脏。采用先进的处理算法将复杂的波场分解成更简单的单向波场，用于大视场定量弹性成像的重建。这个 学习有三个目的。目标1：在传统超声扫描仪上实施和推进RESTUE。我们将在传统的临床扫描仪上实施RESTUE，并研究先进的横波产生、检测(通过谐波成像和编码激励)和处理方法，以方便肥胖患者的临床使用和可靠的性能。我们将把Revue扩展到3D成像，以便对肝脏进行更准确和全面的评估。目标1包括人体模型和初步人体研究，以验证所开发的技术。目的2：重复性和重复性研究。我们将使用目标1中的REVUE原型来研究45名MRE患者。每个患者将有3次Revue成像会议：每个会议有3次由3名超声医师执行的独立扫描(总共9次扫描)。前两次会议将以10分钟的休息时间分开，第三次会议将在不同的日期进行。组内相关系数(ICC)将用于评估重测的重复性和评分者间的一致性。还将对Revue的总体测量差异进行估计。目的3：在体内与MRE进行比较。我们将使用REVUE对220名患者进行研究，并将结果与MRE和最先进的超声弹性成像仪(Aixplorer(R))的结果进行比较。数据分析包括测量成功率、与MRE结果的相关性以及对区分最小纤维化(MRE=2.9kPa)和晚期纤维化(MRE=5.0kPa)患者的ROC(接收器操作特征)性能评估。该项目的成功完成将带来一种快速、低成本、深度穿透的超声弹性成像方法，满足肥胖患者肝纤维化分期的关键需求。在这项提案中使用传统的临床超声扫描仪为这项技术的临床实施提供了一条明确的途径。